(Q45220774)

11 December 2017

title

Philinopside A, a novel marine-derived compound possessing dual anti-angiogenic and anti-tumor effects (English)

1 reference

Colochirus quadrangularis

11 December 2017

main subject

angiogenesis inhibitor

1 reference

1 reference

1 reference

Yunguang Tong

1

1 reference

11 December 2017

Xiongwen Zhang

2

1 reference

11 December 2017

Fang Tian

3

1 reference

11 December 2017

Yanghua Yi

4

1 reference

11 December 2017

Qiangzhi Xu

5

1 reference

11 December 2017

Ling Li

6

1 reference

11 December 2017

Linjiang Tong

7

1 reference

11 December 2017

Liping Lin

8

1 reference

11 December 2017

Jian Ding

9

1 reference

11 December 2017

language of work or name

English

0 references

publication date

2005

1 reference

Crossref

full work available at URL

16 September 2022

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ijc.20804

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.1002/ijc.20804?email=unpaywall_01@example.com

published in

International Journal of Cancer

1 reference

11 December 2017

volume

114

1 reference

11 December 2017

issue

6

1 reference

11 December 2017

page(s)

843-853

1 reference

https://api.unpaywall.org/v2/10.1002/ijc.20804?email=unpaywall_01@example.com

11 December 2017

1 reference

19 March 2024

access restriction status

open access

1 reference

based on heuristic

inferred from online access status

cites work

Particle-mediated gene transfer with transforming growth factor-beta1 cDNAs enhances wound repair in rat skin

1 reference

9 March 2024

https://opencitations.net/index/api/v1/references/10.1002/IJC.20804

Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer

1 reference

9 March 2024

https://opencitations.net/index/api/v1/references/10.1002/IJC.20804

Monoclonal antibody strategies to block angiogenesis

1 reference

9 March 2024

https://opencitations.net/index/api/v1/references/10.1002/IJC.20804

Preclinical studies of the combination of angiogenic inhibitors with cytotoxic agents

1 reference

9 March 2024

https://opencitations.net/index/api/v1/references/10.1002/IJC.20804

Receptor tyrosine kinases as targets for inhibition of angiogenesis

1 reference

9 March 2024

https://opencitations.net/index/api/v1/references/10.1002/IJC.20804

1 reference

9 March 2024

https://opencitations.net/index/api/v1/references/10.1002/IJC.20804

Small molecule inhibitors of tumor-promoted angiogenesis, including protein tyrosine kinase inhibitors

1 reference

9 March 2024

https://opencitations.net/index/api/v1/references/10.1002/IJC.20804

Tyrosine kinase activity of purified recombinant cytoplasmic domain of platelet-derived growth factor beta-receptor (beta-PDGFR) and discovery of a novel inhibitor of receptor tyrosine kinases

1 reference

9 March 2024

https://opencitations.net/index/api/v1/references/10.1002/IJC.20804

A new tyrosine kinase inhibitor from the marine brown alga Stypopodium zonale

1 reference

9 March 2024

https://opencitations.net/index/api/v1/references/10.1002/IJC.20804

Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines

1 reference

9 March 2024

https://opencitations.net/index/api/v1/references/10.1002/IJC.20804

Angiogenesis as a target for cancer therapy

1 reference

9 March 2024

https://opencitations.net/index/api/v1/references/10.1002/IJC.20804

Vascular endothelial growth factor and platelet-derived growth factor are potential angiogenic and metastatic factors in human breast cancer

1 reference

9 March 2024

https://opencitations.net/index/api/v1/references/10.1002/IJC.20804

Vascular endothelial growth factor: molecular and biological aspects

1 reference

9 March 2024

https://opencitations.net/index/api/v1/references/10.1002/IJC.20804

Diminished Heparin Binding of a Basic Fibroblast Growth Factor Mutant Is Associated with Reduced Receptor Binding, Mitogenesis, Plasminogen Activator Induction, and in vitro Angiogenesis

1 reference

9 March 2024

https://opencitations.net/index/api/v1/references/10.1002/IJC.20804

Marine sponge polyketide inhibitors of protein tyrosine kinase

1 reference

9 March 2024

https://opencitations.net/index/api/v1/references/10.1002/IJC.20804

Expression of the angiogenic factors, basic fibroblast growth factor and vascular endothelial growth factor, in the ovary

1 reference

9 March 2024

https://opencitations.net/index/api/v1/references/10.1002/IJC.20804

Inhibition of tumor angiogenesis by synthetic receptor tyrosine kinase inhibitors

1 reference

9 March 2024

https://opencitations.net/index/api/v1/references/10.1002/IJC.20804

Regulation of angiogenesis by hypoxia: role of the HIF system

1 reference

9 March 2024

https://opencitations.net/index/api/v1/references/10.1002/IJC.20804

VEGF: an update on biological and therapeutic aspects

1 reference

9 March 2024

https://opencitations.net/index/api/v1/references/10.1002/IJC.20804

Drugs from the deep: marine natural products as drug candidates

1 reference

9 March 2024

https://opencitations.net/index/api/v1/references/10.1002/IJC.20804

Oversulfated fucoidan inhibits the basic fibroblast growth factor-induced tube formation by human umbilical vein endothelial cells: its possible mechanism of action.

1 reference

9 March 2024

https://opencitations.net/index/api/v1/references/10.1002/IJC.20804

Comparison of several antiangiogenic regimens alone and with cytotoxic therapies in the Lewis lung carcinoma

1 reference

9 March 2024

https://opencitations.net/index/api/v1/references/10.1002/IJC.20804

Antiangiogenic activity of aeroplysinin-1, a brominated compound isolated from a marine sponge

1 reference

9 March 2024

https://opencitations.net/index/api/v1/references/10.1002/IJC.20804

Endogenous angiogenesis inhibitors and their therapeutic implications

1 reference

9 March 2024

https://opencitations.net/index/api/v1/references/10.1002/IJC.20804

VEGFs, receptors and angiogenesis

1 reference

9 March 2024

https://opencitations.net/index/api/v1/references/10.1002/IJC.20804

Tranilast inhibits protein kinase C-dependent signalling pathway linked to angiogenic activities and gene expression of retinal microcapillary endothelial cells

1 reference

9 March 2024

https://opencitations.net/index/api/v1/references/10.1002/IJC.20804

Inhibitory effects of anti-angiogenic agents on neovascularization and growth of the chorioallantoic membrane (CAM). The possibility of a new CAM assay for angiogenesis inhibition

1 reference

9 March 2024

https://opencitations.net/index/api/v1/references/10.1002/IJC.20804

Autocrinological role of basic fibroblast growth factor on tube formation of vascular endothelial cells in vitro

1 reference

9 March 2024

https://opencitations.net/index/api/v1/references/10.1002/IJC.20804

Angiogenesis in cancer, vascular, rheumatoid and other disease

1 reference

9 March 2024

https://opencitations.net/index/api/v1/references/10.1002/IJC.20804

Growth factors in glioma angiogenesis: FGFs, PDGF, EGF, and TGFs

1 reference

9 March 2024

https://opencitations.net/index/api/v1/references/10.1002/IJC.20804

Drugs from the seas - current status and microbiological implications

1 reference

9 March 2024

https://opencitations.net/index/api/v1/references/10.1002/IJC.20804

A phase II study of ET-743/trabectedin ('Yondelis') for patients with advanced gastrointestinal stromal tumours

1 reference

9 March 2024

https://opencitations.net/index/api/v1/references/10.1002/IJC.20804

In vitro angiogenesis on the human amniotic membrane: requirement for basic fibroblast growth factor-induced proteinases.

1 reference

9 March 2024

https://opencitations.net/index/api/v1/references/10.1002/IJC.20804

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

1 reference

9 March 2024

https://opencitations.net/index/api/v1/references/10.1002/IJC.20804

Tumor angiogenesis as a therapeutic target

1 reference

9 March 2024

https://opencitations.net/index/api/v1/references/10.1002/IJC.20804

Recombinant human erythropoietin stimulates angiogenesis in vitro

1 reference

9 March 2024

https://opencitations.net/index/api/v1/references/10.1002/IJC.20804

Expression of vascular endothelial growth factor (VEGF) during folliculogenesis and corpus luteum formation in the human ovary

1 reference

9 March 2024

https://opencitations.net/index/api/v1/references/10.1002/IJC.20804

Enhanced antitumour efficacy by combining conventional chemotherapy with angiostatin or endostatin in a liver metastasis model

1 reference

9 March 2024

https://opencitations.net/index/api/v1/references/10.1002/IJC.20804

Identifiers

DOI

10.1002/IJC.20804

1 reference

11 December 2017

1 reference